INMODE LTD (INMD) Stock Fundamental Analysis
NASDAQ:INMD - Nasdaq - IL0011595993 - Common Stock - Currency: USD
We assign a fundamental rating of 7 out of 10 to INMD. INMD was compared to 187 industry peers in the Health Care Equipment & Supplies industry. Both the health and profitability get an excellent rating, making INMD a very profitable company, without any liquidiy or solvency issues. INMD is valued quite cheap, while showing a decent growth score. This is a good combination! These ratings would make INMD suitable for value investing!
1. Profitability
1.1 Basic Checks
INMD had positive earnings in the past year.
In the past year INMD had a positive cash flow from operations.
Each year in the past 5 years INMD has been profitable.
Each year in the past 5 years INMD had a positive operating cash flow.
1.2 Ratios
INMD's Return On Assets of 24.94% is amongst the best of the industry. INMD outperforms 98.40% of its industry peers.
The Return On Equity of INMD (28.38%) is better than 97.33% of its industry peers.
INMD's Return On Invested Capital of 15.86% is amongst the best of the industry. INMD outperforms 96.79% of its industry peers.
The Average Return On Invested Capital over the past 3 years for INMD is significantly above the industry average of 7.89%.
The last Return On Invested Capital (15.86%) for INMD is well below the 3 year average (22.89%), which needs to be investigated, but indicates that INMD had better years and this may not be a problem.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 24.94% | ||
| ROE | 28.38% | ||
| ROIC | 15.86% |
ROA(3y)23.69%
ROA(5y)26.18%
ROE(3y)26.67%
ROE(5y)29.84%
ROIC(3y)22.89%
ROIC(5y)25.97%
1.3 Margins
INMD's Profit Margin of 44.80% is amongst the best of the industry. INMD outperforms 98.40% of its industry peers.
INMD's Profit Margin has improved in the last couple of years.
With an excellent Operating Margin value of 28.05%, INMD belongs to the best of the industry, outperforming 96.79% of the companies in the same industry.
INMD's Operating Margin has declined in the last couple of years.
The Gross Margin of INMD (80.03%) is better than 93.58% of its industry peers.
INMD's Gross Margin has declined in the last couple of years.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 28.05% | ||
| PM (TTM) | 44.8% | ||
| GM | 80.03% |
OM growth 3Y-15.26%
OM growth 5Y-5.64%
PM growth 3Y-0.16%
PM growth 5Y3.28%
GM growth 3Y-1.88%
GM growth 5Y-1.59%
2. Health
2.1 Basic Checks
INMD has a Return on Invested Capital (ROIC), which is well above the Cost of Capital (WACC), which means it is creating value.
Compared to 1 year ago, INMD has less shares outstanding
The number of shares outstanding for INMD has been increased compared to 5 years ago.
INMD has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
2.2 Solvency
INMD has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0 | ||
| Debt/FCF | 0 | ||
| Altman-Z | N/A |
ROIC/WACC1.75
WACC9.07%
2.3 Liquidity
INMD has a Current Ratio of 8.73. This indicates that INMD is financially healthy and has no problem in meeting its short term obligations.
With an excellent Current ratio value of 8.73, INMD belongs to the best of the industry, outperforming 89.84% of the companies in the same industry.
INMD has a Quick Ratio of 7.86. This indicates that INMD is financially healthy and has no problem in meeting its short term obligations.
INMD has a better Quick ratio (7.86) than 91.44% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 8.73 | ||
| Quick Ratio | 7.86 |
3. Growth
3.1 Past
The earnings per share for INMD have decreased strongly by -25.00% in the last year.
The Earnings Per Share has been growing by 22.97% on average over the past years. This is a very strong growth
The Revenue for INMD has decreased by -15.84% in the past year. This is quite bad
INMD shows a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 20.35% yearly.
EPS 1Y (TTM)-25%
EPS 3Y-4.52%
EPS 5Y22.97%
EPS Q2Q%-3.13%
Revenue 1Y (TTM)-15.84%
Revenue growth 3Y3.36%
Revenue growth 5Y20.35%
Sales Q2Q%-3%
3.2 Future
The Earnings Per Share is expected to grow by 6.28% on average over the next years.
The Revenue is expected to grow by 3.35% on average over the next years.
EPS Next Y-3.22%
EPS Next 2Y4.02%
EPS Next 3Y6.28%
EPS Next 5YN/A
Revenue Next Year-4.12%
Revenue Next 2Y0.26%
Revenue Next 3Y3.35%
Revenue Next 5YN/A
3.3 Evolution
When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
4. Valuation
4.1 Price/Earnings Ratio
With a Price/Earnings ratio of 8.56, the valuation of INMD can be described as very reasonable.
Based on the Price/Earnings ratio, INMD is valued cheaply inside the industry as 97.33% of the companies are valued more expensively.
The average S&P500 Price/Earnings ratio is at 27.45. INMD is valued rather cheaply when compared to this.
Based on the Price/Forward Earnings ratio of 7.87, the valuation of INMD can be described as very cheap.
Compared to the rest of the industry, the Price/Forward Earnings ratio of INMD indicates a rather cheap valuation: INMD is cheaper than 96.79% of the companies listed in the same industry.
INMD is valuated cheaply when we compare the Price/Forward Earnings ratio to 21.90, which is the current average of the S&P500 Index.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 8.56 | ||
| Fwd PE | 7.87 |
4.2 Price Multiples
99.47% of the companies in the same industry are more expensive than INMD, based on the Enterprise Value to EBITDA ratio.
Compared to the rest of the industry, the Price/Free Cash Flow ratio of INMD indicates a rather cheap valuation: INMD is cheaper than 97.86% of the companies listed in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 7.86 | ||
| EV/EBITDA | 1.99 |
4.3 Compensation for Growth
INMD has an outstanding profitability rating, which may justify a higher PE ratio.
PEG (NY)N/A
PEG (5Y)0.37
EPS Next 2Y4.02%
EPS Next 3Y6.28%
5. Dividend
5.1 Amount
No dividends for INMD!.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
15.16
-0.05 (-0.33%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)
Earnings (Next)
Inst Owners72.46%
Inst Owner Change1.86%
Ins Owners10.65%
Ins Owner ChangeN/A
Market Cap958.26M
Analysts72.31
Price Target17.39 (14.71%)
Short Float %10.13%
Short Ratio3.72
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-16.98%
Min EPS beat(2)-20.27%
Max EPS beat(2)-13.69%
EPS beat(4)1
Avg EPS beat(4)-9.56%
Min EPS beat(4)-20.27%
Max EPS beat(4)8.88%
EPS beat(8)3
Avg EPS beat(8)-6.75%
EPS beat(12)7
Avg EPS beat(12)-0.58%
EPS beat(16)11
Avg EPS beat(16)2.13%
Revenue beat(2)0
Avg Revenue beat(2)-6.17%
Min Revenue beat(2)-9.96%
Max Revenue beat(2)-2.38%
Revenue beat(4)1
Avg Revenue beat(4)-7.11%
Min Revenue beat(4)-16.64%
Max Revenue beat(4)0.53%
Revenue beat(8)2
Avg Revenue beat(8)-6.51%
Revenue beat(12)6
Avg Revenue beat(12)-2.94%
Revenue beat(16)10
Avg Revenue beat(16)-0.79%
PT rev (1m)-8.05%
PT rev (3m)-20.08%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-14.53%
EPS NY rev (1m)-0.19%
EPS NY rev (3m)-13.35%
Revenue NQ rev (1m)0.23%
Revenue NQ rev (3m)-0.31%
Revenue NY rev (1m)-0.24%
Revenue NY rev (3m)-1.73%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 8.56 | ||
| Fwd PE | 7.87 | ||
| P/S | 2.44 | ||
| P/FCF | 7.86 | ||
| P/OCF | 7.82 | ||
| P/B | 1.55 | ||
| P/tB | 1.55 | ||
| EV/EBITDA | 1.99 |
EPS(TTM)1.77
EY11.68%
EPS(NY)1.93
Fwd EY12.7%
FCF(TTM)1.93
FCFY12.73%
OCF(TTM)1.94
OCFY12.79%
SpS6.21
BVpS9.8
TBVpS9.8
PEG (NY)N/A
PEG (5Y)0.37
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 24.94% | ||
| ROE | 28.38% | ||
| ROCE | 17.41% | ||
| ROIC | 15.86% | ||
| ROICexc | 84.14% | ||
| ROICexgc | 84.14% | ||
| OM | 28.05% | ||
| PM (TTM) | 44.8% | ||
| GM | 80.03% | ||
| FCFM | 31.08% |
ROA(3y)23.69%
ROA(5y)26.18%
ROE(3y)26.67%
ROE(5y)29.84%
ROIC(3y)22.89%
ROIC(5y)25.97%
ROICexc(3y)532.49%
ROICexc(5y)5023.19%
ROICexgc(3y)532.49%
ROICexgc(5y)5023.19%
ROCE(3y)25.13%
ROCE(5y)28.51%
ROICexcg growth 3Y-60.68%
ROICexcg growth 5YN/A
ROICexc growth 3Y-60.68%
ROICexc growth 5YN/A
OM growth 3Y-15.26%
OM growth 5Y-5.64%
PM growth 3Y-0.16%
PM growth 5Y3.28%
GM growth 3Y-1.88%
GM growth 5Y-1.59%
F-Score6
Asset Turnover0.56
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0 | ||
| Debt/FCF | 0 | ||
| Debt/EBITDA | 0 | ||
| Cap/Depr | 87.11% | ||
| Cap/Sales | 0.16% | ||
| Interest Coverage | 250 | ||
| Cash Conversion | 110.65% | ||
| Profit Quality | 69.38% | ||
| Current Ratio | 8.73 | ||
| Quick Ratio | 7.86 | ||
| Altman-Z | N/A |
F-Score6
WACC9.07%
ROIC/WACC1.75
Cap/Depr(3y)144.54%
Cap/Depr(5y)147.73%
Cap/Sales(3y)0.22%
Cap/Sales(5y)0.23%
Profit Quality(3y)91.09%
Profit Quality(5y)96.73%
High Growth Momentum
Growth
EPS 1Y (TTM)-25%
EPS 3Y-4.52%
EPS 5Y22.97%
EPS Q2Q%-3.13%
EPS Next Y-3.22%
EPS Next 2Y4.02%
EPS Next 3Y6.28%
EPS Next 5YN/A
Revenue 1Y (TTM)-15.84%
Revenue growth 3Y3.36%
Revenue growth 5Y20.35%
Sales Q2Q%-3%
Revenue Next Year-4.12%
Revenue Next 2Y0.26%
Revenue Next 3Y3.35%
Revenue Next 5YN/A
EBIT growth 1Y-36.29%
EBIT growth 3Y-12.42%
EBIT growth 5Y13.55%
EBIT Next Year-31.82%
EBIT Next 3Y-5%
EBIT Next 5YN/A
FCF growth 1Y-27.92%
FCF growth 3Y-8.8%
FCF growth 5Y16.5%
OCF growth 1Y-28.22%
OCF growth 3Y-8.8%
OCF growth 5Y16.36%